+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

ELISpot and FluoroSpot Assay Market by Product (Assay Kit (T Cell and B Cell assay), Analyzer, Ancillary Products), Application (Transplant, Vaccines, Clinical Trials, Cancer), End User (Hospital, Labs, Research Institute) - Global Forecast to 2023

  • ID: 4714901
  • Report
  • Region: Global
  • 112 Pages
  • Markets and Markets
1 of 6
ELISpot and FluoroSpot Assay Market to Register a CAGR of 16.2% from 2018 to 2023

FEATURED COMPANIES

  • Abcam
  • Bio-Techne
  • Lophius Biosciences GmbH
  • Mabtech AB
  • Oxford Immunotec
  • U-Cytech Biosciences
  • MORE

“ELISpot and FluoroSpot Assay market to register a CAGR of 16.2% from 2018 to 2023”

The ELISpot and FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period. The rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot and FluoroSpot assay kits and analyzers, are factors expected to drive market growth during the forecast period. The use of FluoroSpot assays for multiple-analyte detection in a single well is also expected to provide opportunities for the growth of the market.

“Assay Kits are expected to account for a significant share of the market in 2018”

By product, the ELISpot and FluoroSpot market is segmented into assay kits, analyzers, and ancillary products. The assay kits segment is further sub-segmented by utility, type, and analyte. In 2018, the assay kits segment is expected to account for the largest market share. This segment is also expected to grow at the highest CAGR during the forecast period. The rising incidence of chronic diseases and technological advancements are driving the growth of this product segment.

“Diagnostic applications to hold the majority share in the ELISpot and FluoroSpot market in 2018”

On the basis of application, the ELISpot and FluoroSpot market is segmented into research and diagnostic applications. In 2018, the diagnostics segment is expected to account for the larger share of the ELISpot and FluoroSpot market. The large share of this segment can be attributed to the rising global prevalence of infectious diseases and the increasing use of ELISpot kits for disease diagnosis.

“North America to dominate the ELISpot and FluoroSpot market in 2018”

North America which includes the US and Canada, is expected to account for the largest share of the ELISpot and FluoroSpot market. The large share of this market segment can be attributed to the increasing incidence of chronic diseases. In addition to this, the increasing focus on vaccine development is driving the growth of this market.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 - 20% , Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, Director-level - 20%, and Others - 50%
  • By Region: North America - 35%, Europe - 24%, Asia - 25%, and RoW - 16%

Research Coverage
This report studies the ELISpot and FluoroSpot market based on product, application, end user, and region. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total ELISpot and FluoroSpot market. The report forecasts the revenue of the market segments with respect to four major regions.
 
Reasons to Buy the Report:
The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on ELISpot and FluoroSpot products offered by the top 10 players in the ELISpot and FluoroSpot market. The report analyzes the ELISpot and FluoroSpot market by product, end user, application, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various ELISpot and FluoroSpot across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the ELISpot and FluoroSpot market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the ELISpot and FluoroSpot market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abcam
  • Bio-Techne
  • Lophius Biosciences GmbH
  • Mabtech AB
  • Oxford Immunotec
  • U-Cytech Biosciences
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 ELISpot and FluoroSpot: Market Overview
4.2 North America: ELISpot and FluoroSpot Market, By Product (2018)
4.3 Geographical Snapshot of the ELISpot and FluoroSpot Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Global Incidence of Chronic Diseases
5.2.1.2 Increasing Vaccine Development to Address the Challenge of Antimicrobial Resistance
5.2.1.3 Technological Advancements in ELISpot and FluoroSpot Assay Kits and Analyzers
5.2.2 Opportunities
5.2.2.1 Use of FluoroSpot Assays for Multiple-Analyte Detection in A Single Well
5.2.3 Challenges
5.2.3.1 Availability of Alternative Detection Technologies

6 ELISpot and FluoroSpot Market, By Product
6.1 Introduction
6.2 Assay Kits
6.2.1 Assay Kits Market, By Technique
6.2.1.1 ELISpot Assay Kits
6.2.1.1.1 Majority of Kits Available in the Market are ELISpot Kits
6.2.1.2 FluoroSpot Assay Kits
6.2.1.2.1 Increasing Demand for Multiple Analyte Detection and Technological Advancement are Driving Segmental Growth
6.2.2 Assay Kits Market, By Utility
6.2.2.1 Diagnostic Kits
6.2.2.1.1 Diagnostic Kits are Six to Eight Times Costlier Than Research Kits
6.2.2.2 Research Kits
6.2.2.2.1 Market Growth Driven By Continued Investment in Vaccine Research, Clinical Trials, and Cancer Research
6.2.3 Assay Kits Market, By Analyte
6.2.3.1 T-Cell-Based Kits
6.2.3.1.1 Low Concentrations of Infection-Released Analytes Necessitates Use of T-Cell-Based Kits
6.2.3.2 B-Cell-Based Kits
6.2.3.2.1 Detection of B-Cell-Based Antibodies is Useful to Study Cell Response Post-Infection/Vaccination
6.2.3.3 Other Analyte Kits
6.3 Analyzers
6.3.1 Adoption of Assay Kits Will Drive the Use of Analyzers
6.4 Ancillary Products
6.4.1 Market Players Such as Thermo Fisher Scientific Provide Ancillary Products

7 ELISpot and FluoroSpot Market, By Application
7.1 Introduction
7.2 Diagnostic Applications
7.2.1 Infectious Diseases
7.2.1.1 Infectious Diseases Segment to Dominate the Diagnostic Applications Market During the Forecast Period
7.2.2 Transplants
7.2.2.1 Growing Incidence of Infections Caused During Transplant Procedures are Driving the Demand for ELISpot and FluoroSpot Assays
7.3 Research Applications
7.3.1 Vaccine Development
7.3.1.1 Vaccine Development Segment to Register the Highest Growth Rate in the Forecast Period
7.3.2 Clinical Trials
7.3.2.1 Growing Number of Clinical Trials are Driving the Demand for ELISpot and FluoroSpot Assays
7.3.3 Cancer Research
7.3.3.1 Rising Global Prevalence of Cancer is Driving the Growth of the ELISpot and FluoroSpot Market

8 ELISpot and FluoroSpot Market, By End User
8.1 Introduction
8.2 Hospitals & Clinical Laboratories
8.2.1 Hospitals & Clinical Laboratories to Account for the Largest Market Share in 2018
8.3 Research Institutes
8.3.1 Research Institutes are the Fastest-Growing End Users of the ELISpot and FluoroSpot Market
8.4 Biopharmaceutical Companies
8.4.1 Biopharmaceutical Companies Use ELISpot and FluoroSpot Assays for Vaccine Development, Clinical Trials, and Cancer Research

9 ELISpot and FluoroSpot Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Will Continue to Dominate the North American ELISpot and FluoroSpot Market During the Forecast Period
9.2.2 Canada
9.2.2.1 High Burden of Chronic Diseases in the Country to Drive the Adoption of ELISpot and FluoroSpot Assays
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany to Be the Fastest-Growing Country in the European ELISpot and FluoroSpot Market
9.3.2 UK
9.3.2.1 Rising Prevalence of Ncds in the UK to Drive Market Growth
9.3.3 France
9.3.3.1 Chronic Ncds Form A Key Cause of Death in France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China’s Large Vaccine Industry Provides Favorable Outlook for ELISpot and FluoroSpot Assays
9.4.2 India
9.4.2.1 High Incidence of Chronic Diseases and Growing Vaccine R&D Activity Will Contribute to Market Growth
9.4.3 Japan
9.4.3.1 Chronic Ncds are Responsible for A Large Chunk of Deaths in Japan
9.4.4 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking Analysis, 2017
10.2.1 Top Players in Research-Use Kits Market
10.2.2 Top Players in ELISpot and FluoroSpot Analyzers Market
10.3 Key Strategies
10.3.1 Product Launches
10.3.2 Expansions
10.3.3 Agreements
10.3.4 Acquisitions
10.3.5 Patents
10.3.6 Product Approval

11 Company Profiles
11.1 Oxford Immunotec
11.2 Cellular Technology Limited (CTL)
11.3 Mabtech AB
11.4 Becton, Dickinson and Company
11.5 Abcam
11.6 Bio-Techne
11.7 Autoimmun Diagnostika GmbH
11.8 Biotech Investissement Group
11.9 Lophius Biosciences GmbH
11.10 U-Cytech Biosciences

12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables
Table 1 ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 2 ELISpot and FluoroSpot Assay Kits Market, By Region, 2016–2023 (USD Million)
Table 3 ELISpot and FluoroSpot Assay Kits Market, By Technique, 2016-2023 (USD Million)
Table 4 ELISpot Assay Kits Market, By Region, 2016-2023 (USD Million)
Table 5 FluoroSpot Assay Kits Market, By Region, 2015-2023 (USD Million)
Table 6 ELISpot and FluoroSpot Assay Kits Market, By Utility, 2016-2023 (USD Million)
Table 7 Diagnostic Kits Market, By Region, 2016-2023 (USD Million)
Table 8 Research Kits Market, By Region, 2016-2023 (USD Million)
Table 9 Assay Kits Market, By Analyte, 2016-2023 (USD Million)
Table 10 T-Cell-Based Kits Market, By Region, 2016-2023 (USD Million)
Table 11 B-Cell-Based Kits Market, By Region, 2016-2023 (USD Million)
Table 12 Other Analyte Kits Market, By Region, 2016-2023 (USD Million)
Table 13 ELISpot and FluoroSpot Analyzers Market, By Region, 2016-2023 (USD Million)
Table 14 ELISpot and FluoroSpot Ancillary Products Market, By Region, 2016-2023 (USD Million)
Table 15 ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 16 ELISpot and FluoroSpot Market for Diagnostic Applications, By Type, 2016–2023 (USD Million)
Table 17 ELISpot and FluoroSpot Market for Diagnostic Applications, By Region, 2016–2023 (USD Million)
Table 18 ELISpot and FluoroSpot Market for Infectious Diseases, By Region, 2016–2023 (USD Million)
Table 19 ELISpot and FluoroSpot Market for Transplants, By Region, 2016–2023 (USD Million)
Table 20 ELISpot and FluoroSpot Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 21 ELISpot and FluoroSpot Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 22 ELISpot and FluoroSpot Market for Vaccine Development, By Region, 2016–2023 (USD Million)
Table 23 ELISpot and FluoroSpot Market for Clinical Trials, By Region, 2016–2023 (USD Million)
Table 24 ELISpot and FluoroSpot Market for Cancer Research, By Region, 2016–2023 (USD Million)
Table 25 ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 26 ELISpot and FluoroSpot Market for Hospitals & Clinical Laboratories, By Region, 2016–2023 (USD Million)
Table 27 ELISpot and FluoroSpot Market for Research Institutes, By Region, 2016–2023 (USD Million)
Table 28 ELISpot and FluoroSpot Market for Biopharmaceutical Companies, By Region, 2016–2023 (USD Million)
Table 29 ELISpot and FluoroSpot Market, By Region, 2016–2023 (USD Million)
Table 30 North America: ELISpot and FluoroSpot Market, By Country, 2016–2023 (USD Million)
Table 31 North America: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 32 North America: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 33 North America: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 34 US: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 35 US: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 36 US: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 37 Canada: ELISpot and FluoroSpot Market, By Product, 2018–2023 (USD Million)
Table 38 Canada: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 39 Canada: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 40 Europe: ELISpot and FluoroSpot Market, By Country, 2016–2023 (USD Million)
Table 41 Europe: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 42 Europe: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 43 Europe: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 44 Germany: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 45 Germany: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 46 Germany: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 47 UK: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 48 UK: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 49 UK: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 50 France: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 51 France: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 52 France: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 53 RoE: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 54 RoE: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 55 RoE: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 56 Asia Pacific: ELISpot and FluoroSpot Market, By Country, 2016–2023 (USD Million)
Table 57 Asia Pacific: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 58 Asia Pacific: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 59 Asia Pacific: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 60 China: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 61 China: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 62 China: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 63 India: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 64 India: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 65 India: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 66 Japan: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 67 Japan: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 68 Japan: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 69 RoAPAC: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 70 RoAPAC: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 71 RoAPAC: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)
Table 72 RoW: ELISpot and FluoroSpot Market, By Product, 2016–2023 (USD Million)
Table 73 RoW: ELISpot and FluoroSpot Market, By Application, 2016–2023 (USD Million)
Table 74 RoW: ELISpot and FluoroSpot Market, By End User, 2016–2023 (USD Million)

List of Figures
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 ELISpot and FluoroSpot Market: Bottom-Up Approach
Figure 4 ELISpot and FluoroSpot Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 ELISpot and FluoroSpot Market, By Product, 2018 vs 2023 (USD Million)
Figure 7 ELISpot and FluoroSpot Market, By Application, 2018 vs 2023 (USD Million)
Figure 8 ELISpot and FluoroSpot Market, By End User, 2018 vs 2023 (USD Million)
Figure 9 ELISpot and FluoroSpot Market, By Region, 2018 vs 2023 (USD Million)
Figure 10 Rising Global Incidence of Chronic Diseases and Focus on Vaccine Development to Drive Market Growth During the Forecast Period
Figure 11 Assays Kits to Dominate the North American ELISpot and FluoroSpot Market in 2018
Figure 12 Countries in Asia to Register A Higher Growth Rate During the Forecast Period
Figure 13 ELISpot and FluoroSpot Market: Drivers, Opportunities, and Challenges
Figure 14 Assay Kits Segment to Witness the Highest Growth During the Forecast Period
Figure 15 Diagnostic Applications to Dominate the ELISpot and FluoroSpot Market During the Forecast Period
Figure 16 Total Cases of Tick-Borne Diseases in the Us, 2004–2017
Figure 17 Percentage of Registered Studies By Location (As of November 26, 2018)
Figure 18 Research Institutes Segment to Witness the Highest Growth During the Forecast Period
Figure 19 Asia Pacific to Witness the Highest Growth in the ELISpot and FluoroSpot Market During the Forecast Period
Figure 20 North America: ELISpot and FluoroSpot Market Snapshot
Figure 21 Global Vaccine Production
Figure 22 Non-Communicable Diseases in Germany
Figure 23 Non-Communicable Diseases in the UK
Figure 24 Non-Communicable Diseases in France
Figure 25 Asia Pacific: ELISpot and FluoroSpot Market Snapshot
Figure 26 Key Developments in the ELISpot and FluoroSpot Market From 2015 to 2018
Figure 27 ELISpot and FluoroSpot Market Ranking, By Key Player, 2017
Figure 28 Top Players in Research-Use Kits Market
Figure 29 Top Players in ELISpot and FluoroSpot Analyzers Market
Figure 30 Oxford Immunotec: Company Snapshot (2017)
Figure 31 BD: Company Snapshot (2017)
Figure 32 Abcam: Company Snapshot (2017)
Figure 33 Bio-Techne: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Abcam
  • Autoimmun Diagnostika GmbH
  • Becton, Dickinson and Company
  • Bio-Techne
  • Biotech Investissement Group
  • Cellular Technology Limited (CTL)
  • Lophius Biosciences GmbH
  • Mabtech AB
  • Oxford Immunotec
  • U-Cytech Biosciences
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4714901
Adroll
adroll